|
|
|
05 Dec 2007 |
BioInvent Designates Drug Candidate, BI-505, for the Treatment of Cancer
|
|
05 Dec 2007 |
Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product
|
|
05 Dec 2007 |
Genentech Provides Update From Avastin FDA Advisory Meeting
|
|
05 Dec 2007 |
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
|
|
04 Dec 2007 |
Centocor and Janssen-Cilag Submit Appplications Requesting Approval of Ustekinumab in the U.S. and Europe For Treatment of Moderate to Severe Plaque Psoriasis
|
|
04 Dec 2007 |
Arana Announces Phase II Trials For Lead Compound ART621
|
|
04 Dec 2007 |
Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement
|
|
04 Dec 2007 |
Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
|
|
04 Dec 2007 |
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
|
|
03 Dec 2007 |
"Actemra(R)," a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, Filed for Rheumatoid Arthritis in Europe
|
|
02 Dec 2007 |
Novartis further strengthens biologics capabilities in expansion of MorphoSys collaboration
|
|
29 Nov 2007 |
New Data Highlight That Treatment With Erbitux Allows More Resections of Preteated Patients With Metastatic Colorectal Cancer
|
|
29 Nov 2007 |
Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies
|
|
28 Nov 2007 |
MediGene and Celltrion Announce Co-development of Anti-L1 Monoclonal Antibody Therapeutic for Treating Cancer
|
|
26 Nov 2007 |
MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
|
|
21 Nov 2007 |
Roche Submits Application for FDA Approval of Actemra for the Treatment of Rheumatoid Arthritis
|
|
21 Nov 2007 |
Kyto Biopharma Inc. Confirms Definitive Isolation of the Human Vitamin B12 Receptor (TCblR)
|
|
20 Nov 2007 |
Genmab and Glaxosmithkline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
|
|
20 Nov 2007 |
Biogen Idec and Neurimmune Therapeutics Announce Alliance to Develop Treatments for Alzheimer's Disease
|
|
19 Nov 2007 |
Avastin Shows Encouraging Results in Phase II Study in Patients With the Most Aggressive Form of Brain Cancer
|
|
19 Nov 2007 |
Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
|
|
16 Nov 2007 |
CHMP Adopts Negative Opinion on Appeal on European Application For natalizumab for the Treatment of Crohn's Disease
|
|
16 Nov 2007 |
Avastin receives positive opinion in Europe for first-line treatment of patients with advanced kidney cancer
|
|
16 Nov 2007 |
UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
|
|
16 Nov 2007 |
Abbott's HUMIRA(R) Receives Positive Opinion from EMEA for Treatment of Moderate to Severe Plaque Psoriasis
|
|
14 Nov 2007 |
ThromboGenics Begins Preclinical Development of Anti-VPAC Antibody for Thrombocytopenia
|
|
14 Nov 2007 |
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
|
|
13 Nov 2007 |
New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
|
|
12 Nov 2007 |
Major Phase 3 Trial Shows Zevalin(R) Extends Progression-Free Survival in one of the most common types of Lymphoma
|
|
09 Nov 2007 |
Human Genome Sciences Reports Positive Data From Long-Term Treatment With LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
|
|
09 Nov 2007 |
Seattle Genetics Initiates Phase IIb Clinical Trial of SGN-33 in Combination with Chemotherapy for Acute Myeloid Leukemia
|
|
09 Nov 2007 |
Biogen Idec's Baminercept, the First Lymphotoxin-beta Pathway Inhibitor in Development, Shows Promise in Patients with Rheumatoid Arthritis
|
|
08 Nov 2007 |
Dyax Corp. Announces Extension of Antibody Library Collaboration with ImClone Systems
|
|
08 Nov 2007 |
Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
|
|
08 Nov 2007 |
A Second Overseas Phase III Trial Data Demonstrates Efficacy of "Actemra(R)"
|
|
08 Nov 2007 |
Abbott Research Demonstrates Viability of Combining Antibody Functions to Target Two or More Disease-Causing Processes
|
|
06 Nov 2007 |
Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
|
|
06 Nov 2007 |
Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action
|
|
05 Nov 2007 |
Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting
|
|
03 Nov 2007 |
ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis I
|
|
02 Nov 2007 |
Seattle Genetics Initiates SGN-40 Clinical Trial in Combination with Revlimid for Multiple Myeloma
|
|
01 Nov 2007 |
Seattle Genetics and MedImmune Expand Antibody-Drug Conjugate Collaboration
|
|
30 Oct 2007 |
Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
|
|
29 Oct 2007 |
Peptech successfully completes Phase I trial for PN0621
|
|
26 Oct 2007 |
Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers
|
|
26 Oct 2007 |
Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
|
|
25 Oct 2007 |
Human Genome Sciences presents new data showing anti-tumor activity and safety of trail receptor antibodies in combination with chemotherapy
|
|
25 Oct 2007 |
Milatuzumab Showed Promising Therapeutic Effects Alone and Combined With CD20 Antibody in Preclinical Studies
|
|
25 Oct 2007 |
ImmunoGen, Inc. Reports New Clinical and Preclinical Data at AACR-NCI-EORTC
|
|
25 Oct 2007 |
Seattle Genetics Reports Preclinical Data on SGN-40 and an Anti-CD19 Antibody-Drug Conjugate
|
| |
|
Results 301 - 350 of 1043 |
